SAINTE-FOY, QUEBEC--(Marketwire - Nov. 29, 2007) - Bioxel Pharma Inc. (TSX VENTURE:BIP - News), a leading manufacturer of taxane active pharmaceutical ingredients (APIs) and developer of targeted oncology drugs, today announced its results for the third quarter ended September 30, 2007.
